Welcome to our dedicated page for Verano Hldgs news (Ticker: VRNOF), a resource for investors and traders seeking the latest updates and insights on Verano Hldgs stock.
Verano Holdings Corp. (VRNOF) is a vertically integrated cannabis operator with cultivation, production, and retail facilities across regulated U.S. markets. This page aggregates official announcements, financial disclosures, and strategic developments for stakeholders tracking the company’s progress in the evolving cannabis sector.
Investors will find timely updates on quarterly earnings, regulatory compliance milestones, and expansion initiatives like recent entries into new state markets. All content is sourced directly from company filings and verified media partners to ensure accuracy.
The archive includes press releases covering product launches, partnership agreements, and operational updates. Analytical reports detail Verano’s market positioning through retail footprint growth and brand portfolio development.
Bookmark this page for streamlined access to VRNOF’s latest news. Check regularly for updates on legislative changes impacting operations and the company’s responses to industry trends.
Verano Holdings Corp. has opened its 11th Zen Leaf dispensary in Pennsylvania, located in Northeast Philadelphia. This facility enhances access in the state’s largest medical cannabis market, which is projected to reach nearly $1 billion in sales this year. The new dispensary, operating in a high-traffic area with over 60,000 cars daily, is part of Verano's broader strategy to expand its footprint as it prepares for potential adult-use legislation. Another dispensary is set to open next week, continuing Verano's growth in the region.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced that CEO George Archos will participate in Cantor Fitzgerald’s cannabis-focused "Weednesday Series" on July 14 at 11:00 AM ET. This investor fireside chat will be hosted by Pablo Zuanic, a Managing Director at Cantor Fitzgerald. Verano is a leading multi-state cannabis operator in the U.S., focused on improving community wellness through responsible cannabis access. With operations in 11 U.S. states and nine production facilities, Verano offers a range of products under trusted consumer brands.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced the successful closing of transactions for equity interests in Agri-Kind, LLC, and Agronomed Biologics, LLC. Agri-Kind operates a 62,000 sq. ft. indoor cultivation facility in Chester, PA, while Agronomed is building a facility and has permits for six dispensaries in the state. This expansion is poised to strengthen Verano's presence in Pennsylvania, the fifth most populous state, with over 500,000 medical marijuana participants, enhancing growth opportunities for the company's cannabis operations.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) has announced the launch of its Atlas Thrive – Powered by MÜV products in partnership with Atlas Biotechnologies. Starting July 13, 2021, these cannabis products, including transdermal patches, gels, and tinctures, will be sold through Canada’s largest pharmacy chain, Shoppers Drug Mart. This collaboration allows Verano to access a significant market, catering to over 400,000 medical cannabis patients in Canada. The introduction of these innovative products highlights Verano's commitment to expanding its footprint in the cannabis sector.
Verano Holdings Corp. (OTCQX: VRNOF) has successfully acquired Mad River Remedies, enhancing its presence in Ohio with five dispensaries, the maximum allowed. This acquisition positions Verano to serve the Dayton metropolitan area, which has nearly 800,000 residents, and is located near major universities. The company aims to leverage Ohio's growing medical cannabis market to drive revenue growth through its premium cannabis product offerings.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) will announce its Q2 2021 financial results on August 10, 2021, before market open. A conference call for investors will take place at 8:30 a.m. ET, allowing discussion of results and Q&A. Verano operates across 11 states with 14 locations, focusing on premium, innovative cannabis products under brands like Verano, Avexia, and MÜV. The company emphasizes its commitment to communal wellness through accessible cannabis offerings.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced that Chief Investment Officer Aaron Miles will present at VirtualInvestorConferences.com on June 29, 2021, at 10:00 AM ET. This event offers a platform for individual and institutional investors to interact with the company. An archived webcast will be available for those unable to attend live. Verano is a leading multi-state cannabis operator in the U.S., with operations in 11 states, producing premium cannabis products under brands like Verano and Zen Leaf.
Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) announced DTC eligibility for its subordinate voting shares, enhancing liquidity and shareholder access in U.S. capital markets. This move allows for electronic clearing and settlement, facilitating faster trades for current shareholders and attracting new investors. CEO George Archos emphasized that DTC eligibility is crucial for expanding Verano's presence in the market. The company operates across 14 U.S. states, with significant cultivation and retail operations aimed at improving communal wellness through regulated cannabis products.
Verano Holdings Corp. has opened its third Zen Leaf dispensary in New Jersey, located on Route 1 in Lawrence Township. This marks the 78th retail location for the company and is strategically positioned near high traffic areas, including Quakerbridge Mall. The municipality has recently approved adult-use cannabis, allowing for recreational sales to commence when the program launches. Zen Leaf Lawrence offers a variety of cannabis products and aims to meet the growing demand in New Jersey's evolving cannabis market.
Verano Holdings Corp. (OTCQX: VRNOF) announces the opening of its 34th MÜV™ Dispensary in Orlando, Florida, located at 8103 Vineland Ave., on June 4, 2021. The new dispensary is strategically positioned near popular theme parks, maximizing accessibility for the 65 million annual visitors to the region. This facility will offer a wide range of cannabis products including edibles, topicals, and concentrates. Verano aims to enhance patient care with its extensive product offerings and expects strong traffic from both tourists and local medical cannabis patients.
FAQ
What is the current stock price of Verano Hldgs (VRNOF)?
What is the market cap of Verano Hldgs (VRNOF)?
